Graham Capital Management, L.P. Agenus Inc Transaction History

Graham Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 22, 2023	SELL	$1.12 - $1.88 $46,543 - $78,127	-41,557 Reduced 19.39%	172,805 $195,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $280,814 - $437,298	214,362 New	214,362 $342,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $407,125 - $601,160	-173,245 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $505,875 - $994,426	173,245 New	173,245 $557,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.